Idelalisib | 合法藥品大搜索

Medicaluses[edit]...Idelalisibisasecond-linedrugforpatientswhosechroniclymphocyticleukemia(CLL)hasrelapsed.Usedincombinationwithrituximab, ...,LearnaboutZYDELIG®(idelalisib)treatment,includingmanagingsideeffects,anddiscoverhelpfulresourcesrelatedtoyourtreatment.,Idelalisibisatargetedtherapy.Idelalisibisanoralinhibitorofphosphoinositide3-kinase(PI3K)delta,aproteinthatplaysaroleintheactivation, ...,IDENTIFICATIONANDUSE:Idelalisibisawhitetooff-whitepowder.Itisusedasantineoplasticagent,andenzyme...

idelalisib台灣 idelalisib中文 Idelalisib Copanlisib Ibrutinib IMBRUVICA Duvelisib Umbralisib Copanlisib copanlisib中文 copanlisib仿單 copanlisib健保 aliqopa仿單 Copanlisib target Idelalisib Duvelisib duvelisib covid duvelisib manufacturer duvelisib mechanism of action duvelisib withdrawal duvelisib ptcl duvelisib fda approval Umbralisib ibrutinib仿單 ibrutinib健保 ibrutinib價格 ibrutinib中文 ibrutinib副作用 ibrutinib發音億珂膠囊價格 Acalabrutinib idelalisib台灣 idelalisib中文 Ibrutinib IMBRUVICA imbruvica健保 imbruvica價格 imbruvica仿單 imbruvica適應症甘氨酸副作用風濕嗎啡作用時間嗎啡戒斷症狀依必朗股票維他命c不能和什麼一起吃奎寧副作用頗得斯安副作用

Idelalisib | 合法藥品大搜索

Medical uses[edit] ... Idelalisib is a second-line drug for patients whose chronic lymphocytic leukemia (CLL) has relapsed. Used in combination with rituximab, ... Read More

ZYDELIG® (idelalisib) Tablets | 合法藥品大搜索

Learn about ZYDELIG® (idelalisib) treatment, including managing side effects, and discover helpful resources related to your treatment. Read More

Idelalisib (Zydelig) Chemotherapy Drug Information | 合法藥品大搜索

Idelalisib is a targeted therapy. Idelalisib is an oral inhibitor of phosphoinositide 3-kinase (PI3K) delta, a protein that plays a role in the activation, ... Read More

Idelalisib | 合法藥品大搜索

IDENTIFICATION AND USE: Idelalisib is a white to off-white powder. It is used as antineoplastic agent, and enzyme inhibitor. It is indicated for the treatment ... Read More

Zydelig (idelalisib) dosing, indications | 合法藥品大搜索

Medscape - Leukemia and lymphoma dosing for (Zydelig) idelalisib, frequency-based adverse effects, comprehensive interactions, contraindications, ... Read More

Idelalisib | 合法藥品大搜索

由 JR Brown 著作 · 2014 · 被引用 617 次 — Idelalisib, an inhibitor of phosphatidylinositol 3-kinase p110δ, for relapsed/refractory chronic lymphocytic leukemia. Blood. 2014 May 29;123(22):3390-7. Read More

Idelalisib: First | 合法藥品大搜索

由 Q Yang 著作 · 2015 · 被引用 166 次 — Idelalisib [Zydelig (Gilead Sciences, Inc.), also known as CAL-101 and GS-1101] was approved in 2014 in the United States and European Union ... Read More

Zydelig (Idelalisib): First | 合法藥品大搜索

由 LA Raedler 著作 · 2015 · 被引用 16 次 — Zydelig (Idelalisib): First-in-Class PI3 Kinase Inhibitor Approved for the Treatment of 3 Hematologic Malignancies · Small Lymphocytic Lymphoma · Follicular ... Read More

Idelalisib: Uses, Interactions | 合法藥品大搜索

2015年5月8日 — Idelalisib is an antineoplastic kinase inhibitor used to treat chronic lymphocytic leukemia (CLL), relapsed follicular B-cell non-Hodgkin ... Read More

相關資訊整理